Motivista (CT-155)— 510(k) K254038
Substantially EquivalentClick Therapeutics, Inc.
FDA 510(k) clearance K254038 for Motivista (CT-155), Substantially Equivalent on 2026-07-30. Applicant: Click Therapeutics, Inc.. Device class: 2.
Summary
Motivista (CT-155) from Click Therapeutics is filed under SAP, computerized behavioral therapy devices for depressive disorders. The record doesn't describe the product's content or how it's delivered.
Class II, 21 CFR 882.5801. Neurology is both the classification panel and the review panel. It was a Traditional 510(k).
Click Therapeutics filed from New York, New York. The decision came 226 calendar days after FDA received it (December 16, 2025 to July 30, 2026).
Clearance details
- Applicant
- Click Therapeutics, Inc.
- Product code
- Product code SAP
- Device class
- Class 2
- Regulation
- 21 CFR 882.5801
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- New York, NY, US
Recent devices under product code SAP
view allMore clearances from Click Therapeutics, Inc.
view allAdverse events under product code SAP
product code SAP- Other
- 1
- Total
- 1
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.